{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:01Z","timestamp":1790741941372,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jaad.2007.08.014","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T11:54:25Z","timestamp":1200484465000},"page":"403-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Leflunomide as adjuvant treatment of dermatomyositis"],"prefix":"10.1016","volume":"58","author":[{"given":"J. Scott","family":"Boswell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa I.","family":"Costner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.08.014_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","article-title":"Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicenter trial; European leflunomide study group","volume":"353","author":"Smolen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.08.014_bib2","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate; leflunomide rheumatoid arthritis investigators group","volume":"159","author":"Strand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2007.08.014_bib3","first-page":"1521","article-title":"Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial","volume":"31","author":"Kremer","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.08.014_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1517\/14656566.5.5.1083","article-title":"The management of dermatomyositis: current treatment options","volume":"5","author":"Sontheimer","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2007.08.014_bib6","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1074\/jbc.270.21.12398","article-title":"Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide","volume":"270","author":"Xu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2007.08.014_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2007.08.014_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2230.2002.01150.x","article-title":"Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases","volume":"27","author":"Frieling","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib9","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","article-title":"Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Kaltwasser","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2007.08.014_bib10","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1365-2133.2004.05836.x","article-title":"Leflunomide in the treatment of psoriasis: results of a phase II open trial","volume":"150","author":"Tlacuilo-Parra","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib11","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.0007-0963.2003.05846.x","article-title":"Leflunomide as a novel treatment option in severe atopic dermatitis","volume":"150","author":"Schmitt","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/rheumatology\/keg156","article-title":"Successful treatment of sarcoidosis with leflunomide","volume":"42","author":"Majithia","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2007.08.014_bib13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/archderm.136.10.1204","article-title":"Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent","volume":"136","author":"Nousari","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00003088-200241060-00003","article-title":"Clinical pharmacokinetics of leflunomide","volume":"41","author":"Rozman","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaad.2007.08.014_bib15","first-page":"21","article-title":"Leflunomide: a manageable safety profile","volume":"71","author":"van Riel","year":"2004","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.jaad.2007.08.014_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-200427050-00006","article-title":"Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity","volume":"27","author":"van Roon","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2007.08.014_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000051761","article-title":"Vasculitis occurring during leflunomide therapy","volume":"203","author":"Holm","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.08.014_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/rheumatology\/keg120","article-title":"Leflunomide induced vasculitis\u2013a dose-response relationship","volume":"42","author":"Chan","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2007.08.014_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1345\/aph.1E012","article-title":"Leflunomide-associated pancytopenia with or without methotrexate","volume":"38","author":"Chan","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2007.08.014_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/rheumatology\/keh191","article-title":"Peripheral neuropathy in patients on leflunomide","volume":"43","author":"Bharadwaj","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2007.08.014_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clpt.2004.01.016","article-title":"Peripheral neuropathy in patients treated with leflunomide","volume":"75","author":"Bonnel","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2007.08.014_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/41.8.952","article-title":"Peripheral neuropathy: an unwanted effect of leflunomide?","volume":"41","author":"Carulli","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2007.08.014_bib23","first-page":"1160","article-title":"Leflunomide induced acute interstitial pneumonia","volume":"32","author":"Takeishi","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2169\/internalmedicine.43.1201","article-title":"Rheumatoid arthritis complicated with acute intersitial pneumonia induced by leflunomide as an adverse reaction","volume":"43","author":"Kamata","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2007.08.014_bib25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/ard.61.9.850","article-title":"Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis","volume":"61","author":"Soliotis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2007.08.014_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000074120","article-title":"Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide","volume":"207","author":"Fischer","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.08.014_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.2004.01527.x","article-title":"Subacute cutaneous lupus erythematosus associated with leflunomide","volume":"29","author":"Kerr","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.08.014_bib28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/keh586","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Goeb","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2007.08.014_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2003.019323","article-title":"Lupus erythematosus with leflunomide: induction or reactivation?","volume":"64","author":"Gensburger","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207012996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207012996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:11:38Z","timestamp":1759270298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207012996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0190962207012996"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.08.014","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leflunomide as adjuvant treatment of dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}